🇺🇸 FDA
Patent

US 8772256

Codon modified immunogenic compositions and methods of use

granted A61KA61K2039/5256A61K2039/53

Quick answer

US patent 8772256 (Codon modified immunogenic compositions and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/5256, A61K2039/53, A61K2039/545, A61K39/12